Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06894940
What this trial is testing

Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies

Who this might be right for
Multiple Sclerosis
University of Pavia 82
Not applicableEnded earlyNCT04895202
What this trial is testing

Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Study

Who this might be right for
Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity
Novartis Pharmaceuticals 8
Not applicableStudy completedNCT03951181
What this trial is testing

Life-Style Exercise and Activity Package for People Living With Progressive MS

Who this might be right for
Multiple Sclerosis
Cardiff University 21
Early research (Phase 1)Not Yet RecruitingNCT07783269
What this trial is testing

A Basket Study of CTA313 in Participants With Active Autoimmune Diseases

Who this might be right for
Systemic Lupus Erthematosus (SLE)Progressive Multiple Sclerosis (PMS)Autoimmune Encephalitis
Imviva Bio 81
Testing effectiveness (Phase 2)UnknownNCT01144117
What this trial is testing

The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (Primary or Secondary Progressive Phase).
Rigshospitalet, Denmark 56
Not applicableNot Yet RecruitingNCT07631923
What this trial is testing

Acute Intermittent Hypoxia Combined With Gait Training in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+1 more
Shirley Ryan AbilityLab 35
Not applicableLooking for participantsNCT02795052
What this trial is testing

Neurologic Stem Cell Treatment Study

Who this might be right for
Neurologic DisordersNervous System DiseasesNeurodegenerative Diseases+23 more
MD Stem Cells 500
Not applicableAvailableNCT03822858
What this trial is testing

Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Tisch Multiple Sclerosis Research Center of New York
Testing effectiveness (Phase 2)UnknownNCT01815632
What this trial is testing

Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)

Who this might be right for
Progressive Multiple Sclerosis
North Bristol NHS Trust 80
Post-approval studies (Phase 4)UnknownNCT03092544
What this trial is testing

Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients

Who this might be right for
Multiple Sclerosis
Multiple Sclerosis Center of Northeastern New York 57
Early research (Phase 1)Active Not RecruitingNCT06220201
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Who this might be right for
Multiple SclerosisMyasthenia Gravis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 120
Not applicableNot Yet RecruitingNCT06171334
What this trial is testing

Remote Ischemic Conditioning in PPMS

Who this might be right for
Multiple Sclerosis
University of Calgary 45
Early research (Phase 1)UnknownNCT02903537
What this trial is testing

Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive
Fundació Institut Germans Trias i Pujol 16
Large-scale testing (Phase 3)Looking for participantsNCT07299019
What this trial is testing

Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC 990
Testing effectiveness (Phase 2)Study completedNCT02087631
What this trial is testing

Safety and Tolerability of Quetiapine in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Calgary 14
Testing effectiveness (Phase 2)Ended earlyNCT03362294
What this trial is testing

Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS

Who this might be right for
Primary Progressive Multiple Sclerosis
Mapi Pharma Ltd. 30
Large-scale testing (Phase 3)Ended earlyNCT00146159
What this trial is testing

Study Evaluating Mitoxantrone in Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Wyeth is now a wholly owned subsidiary of Pfizer 336
Not applicableLooking for participantsNCT01730131
What this trial is testing

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)

Who this might be right for
Progressive Multifocal Leukoencephalopathy
National Institute of Neurological Disorders and Stroke (NINDS) 700
Testing effectiveness (Phase 2)Study completedNCT02804594
What this trial is testing

Oxidative Pathways in MS Fatigue

Who this might be right for
Progressive Multiple SclerosisFatigue
University of California, San Francisco 15
Not applicableStudy completedNCT02207075
What this trial is testing

Measuring Active Microglia in Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Weill Medical College of Cornell University 50
Next Page